Ebola in the New Yorker (but no Ebola in New York, thankfully) August 19, 2014August 19, 2014 koutterson Bioethics, Biotechnology, FDA, Global Health, Kevin Outterson, Pharmaceuticals, Public Health, Research Funding By Kevin Outterson A short article in the New Yorker on my favorite topic – business models for antibiotic use and innovation. Share this:Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to print (Opens in new window) Related